1. Home
  2. ICUCW vs REGCP Comparison

ICUCW vs REGCP Comparison

Compare ICUCW & REGCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • REGCP
  • Stock Information
  • Founded
  • ICUCW N/A
  • REGCP N/A
  • Country
  • ICUCW United States
  • REGCP United States
  • Employees
  • ICUCW 18
  • REGCP 500
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • REGCP
  • Sector
  • ICUCW Health Care
  • REGCP
  • Exchange
  • ICUCW Nasdaq
  • REGCP Nasdaq
  • Market Cap
  • ICUCW N/A
  • REGCP N/A
  • IPO Year
  • ICUCW 2021
  • REGCP N/A
  • Fundamental
  • Price
  • ICUCW $0.03
  • REGCP $24.52
  • Analyst Decision
  • ICUCW
  • REGCP
  • Analyst Count
  • ICUCW 0
  • REGCP 0
  • Target Price
  • ICUCW N/A
  • REGCP N/A
  • AVG Volume (30 Days)
  • ICUCW N/A
  • REGCP N/A
  • Earning Date
  • ICUCW N/A
  • REGCP N/A
  • Dividend Yield
  • ICUCW N/A
  • REGCP N/A
  • EPS Growth
  • ICUCW N/A
  • REGCP N/A
  • EPS
  • ICUCW N/A
  • REGCP N/A
  • Revenue
  • ICUCW N/A
  • REGCP N/A
  • Revenue This Year
  • ICUCW N/A
  • REGCP N/A
  • Revenue Next Year
  • ICUCW N/A
  • REGCP N/A
  • P/E Ratio
  • ICUCW N/A
  • REGCP N/A
  • Revenue Growth
  • ICUCW N/A
  • REGCP N/A
  • 52 Week Low
  • ICUCW N/A
  • REGCP N/A
  • 52 Week High
  • ICUCW N/A
  • REGCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW 42.56
  • REGCP 60.77
  • Support Level
  • ICUCW $0.03
  • REGCP $24.50
  • Resistance Level
  • ICUCW $0.03
  • REGCP $24.74
  • Average True Range (ATR)
  • ICUCW 0.01
  • REGCP 0.09
  • MACD
  • ICUCW -0.00
  • REGCP -0.00
  • Stochastic Oscillator
  • ICUCW 30.10
  • REGCP 62.88

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About REGCP Regency Centers Corporation

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 482 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

Share on Social Networks: